INTERPACE BIOSCIENCES, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Interpace Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Interpace Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.53M, a 22.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.53M -$446K -22.5% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.64M -$455K -21.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.76M -$542K -23.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.86M -$575K -23.6% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $1.98M +$1.11M +128% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $2.09M -$1.39M -40% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $2.3M -$1.46M -38.9% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $2.44M +$1.16M +90% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $867K -$3.12M -78.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $3.48M -$285K -7.56% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $3.76M -$220K -5.53% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.28M -$3.1M -70.7% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $3.99M -$769K -16.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.77M -$1.4M -27.1% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $3.98M +$1.17M +41.6% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $4.38M +$492K +12.6% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $4.76M Sep 30, 2020 10-Q 2021-01-20
Q2 2020 $5.17M +$2.77M +116% Jun 30, 2020 10-Q/A 2021-01-19
Q1 2020 $2.81M +$411K +17.1% Mar 31, 2020 10-Q/A 2021-01-19
Q4 2019 $3.89M Dec 31, 2019 10-K 2021-04-01
Q2 2019 $2.4M Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $2.4M Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.